Charles Schwab Investment Management Inc Guardant Health, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,003,138 shares of GH stock, worth $47.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,003,138
Previous 1,309,431
23.39%
Holding current value
$47.7 Million
Previous $37.8 Million
39.18%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding GH
# of Institutions
322Shares Held
127MCall Options Held
843KPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA11.7MShares$557 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$535 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$482 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$330 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$285 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.86B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...